MACULA EDEMA AND SILICONE OIL TAMPONADE: CLINICAL FEATURES, PREDICTIVE FACTORS, AND TREATMENT

Retinal DiseasesSurgery and Intervention

An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy

BMC Ophthalmol

Hammer M, Ie A, Eibenberger K, Auffarth GU, Xue K

doi: 10.1186/s12886-024-03834-7

Macular Diseases

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

J Clin Med

Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, Terasaki H, Kondo M, Writing Committee Of Japan-Clinical Retina Study Group J-Crest

doi: 10.3390/jcm13237336

Macular Diseases

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial

JAMA Ophthalmol

Khanani AM, Campochiaro PA, Graff JM, Marcus DM, Miller D, Mittra RA, Regillo C, Sheth VS, Bobbala A, Gune S, Lin S, Quezada-Ruiz C, Malhotra V

doi: 10.1001/jamaophthalmol.2025.0006

Retinal Diseases

Prediction of retinopathy of prematurity development and treatment need with machine learning models

BMC Ophthalmol

Durmaz Engin C, Ozturk T, Ozkan O, Oztas A, Selver MA, Tuzun F

doi: 10.1186/s12886-025-04025-8

Glaucoma and Ocular PressureRetinal Diseases

Predicting Retinal Nerve Fiber Layer Thickness From Ocular Hypertension Treatment Study Optic Disc Photographs

JAMA Ophthalmol

Liu JC, Jammal AA, Scherer R, da Costa DR, Kass M, Gordon M, Medeiros FA

doi: 10.1001/jamaophthalmol.2025.1740

Glaucoma and Ocular Pressure

Identifiable historic and observable factors may predict progression to exfoliation glaucoma in newly-diagnosed exfoliation patients

Ophthalmol Glaucoma

Curtin K, Stein JD, Stagg BC, Fino N, Conley M, Johnson T, Patil A, Paulson C, Pompoco C, Wirostko BM

doi: 10.1016/j.ogla.2024.10.006

Macular Diseases

Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study

Pharmaceuticals (Basel)

Turgut F, Somfai GM, Tappeiner C, Hatz K, Mantel I, Ambresin A, Donati G, Guignard V, Nagyová D, Pfister IB, Schild C, Garweg JG

doi: 10.3390/ph17091235

Glaucoma and Ocular PressureRetinal DiseasesSurgery and Intervention

Silicone Oil and Glaucoma-Related Adverse Events in Pediatric Vitreoretinal Surgery

Ophthalmol Glaucoma

Sharma M, Huertas L, Taylor Gonzalez DJ, Garakani R, Berrocal AM, Chang TC

doi: 10.1016/j.ogla.2025.03.006

Retinal DiseasesSurgery and Intervention

Thirteen year experience of vitrectomy and air tamponade for primary retinal detachment repair with clinical outcomes

Sci Rep

Mete M, Maggio E, Prigione G, Bruni E, Maraone G, Tripodi S, De Santis N, Guerriero M, Pertile G

doi: 10.1038/s41598-024-79889-9

Related content

An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial

Prediction of retinopathy of prematurity development and treatment need with machine learning models

Predicting Retinal Nerve Fiber Layer Thickness From Ocular Hypertension Treatment Study Optic Disc Photographs

Identifiable historic and observable factors may predict progression to exfoliation glaucoma in newly-diagnosed exfoliation patients

Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study

Silicone Oil and Glaucoma-Related Adverse Events in Pediatric Vitreoretinal Surgery

Thirteen year experience of vitrectomy and air tamponade for primary retinal detachment repair with clinical outcomes